Evaluation of the effect of prolongation in eye drug films
Abstract
The work is devoted to the assessment of prolongation in eye drug films. It is shown that the use of prolonged polymer forms of medicines in the treatment of various, including ophthalmic, diseases contributes to increasing the effectiveness and reducing the level of negative effects of the drug on healthy organs.
References
Yershov F. I., Narovlyansky A. N. Use of interferon inducers in viral infections / / journal of Virology 2015. Volume: 60 # 2-P. 5-10
Rashidova S. Sh., Milusheva R. Yu. " Chitin and chitosan Bombyx mori. Synthesis, properties and application", Tashkent, FAN Publishing house, 2009, - P. 246
Klicheva O.B., Aliev Kh.U., Batyrbekov A.A., Rashidova S.Sh. Synthesis of N-carboxymethylchitosan from Bombyx mori and its role in estimating hematological parameters // Chemistry of Natural Compounds, 2017 -№4. - vol 53. - pp. 726-728
Milusheva R. Yu., Rashidova S. sh. "Bioactive properties of nanochitosan bombyx mori", Zh-l high-Molecular compounds, 2017, vol. 56, no. 1, - Pp. 140-146
Sarymsakov A. A., Rashidova S. sh., Aripova T. U. New in the prevention and treatment of influenza and SARS Tashkent, 2010. - P. 110
Aznabaev, M. T. Method of prevention of intraocular infections after cataract phacoemulsification using an ocular medicinal film with levofloxacin / M. T. Aznabaev, G. A. Azamatova / / Bulletin of the Orenburg state University. - 2010. - #12. - P. 8-10.
Vokhmyakov, A.V. Choosing the optimal antibiotic for the prevention of infectious complications in ophthalmic surgery / A.V. Vokhmyakov, I. N. Okolov, P. A. Gurchenok / / Clinical ophthalmology. - 2007. – No. 1. - P. 36-39.
Maychuk, Yu. F. State and prospects of pharmacotherapy of infectious and allergic eye diseases / Yu.F. Maychuk / / Vestn. RAMS. - 2003. – No. 5. - Pp. 23-28.
Milovanova, L. N. Technology of manufacturing medicinal forms / L. N. Milovanova, N. M. Tarusova, E. V. Baboshina. - Rostov-on-don, 2002. - P. 448.
Wispelway, B. Clinical implications of pharmacokinetic and pharmacodynamic of fluoroquinolones / B. Wispelway // J. Clin. Infect. Dis. – 2005. – Vol. 2. – №1. – pp.27-35.